Gen Re Announces New Chief of Decision Analytics
Ausgabe: April 2015 | Life/Health North America
For immediate release
Stamford, CT, April 13, 2015 … Gen Re is pleased to announce Guizhou Hu, MD, PhD, has joined the North American Life/Health division as Chief of Decision Analytics. He is based in Gen Re’s Stamford, CT office reporting to Jim Greenwood, Senior Vice President of the Individual Products Division.
“We’re excited about this new role, and Guizhou’s unique expertise in the field of decision analytics,” said Jim. “His focus will be individual risk assessment through data analytics and research, and ways to assist direct carriers in developing decision analytics initiatives.”
“We’ve been increasingly focused on decision analytics in individual life risk selection these past few years,” said Steve Mannik, President, General Re Life. “Guizhou’s fresh perspective will help us to expand into other areas and offer additional resources to our clients.”
Before joining Gen Re, Guizhou was Chief Scientific Officer at BioSignia for 16 years, where he oversaw their mortality underwriting research and peer review publications. He has a MD from Beijing Medical University and a PhD in epidemiology from Cornell.
Gen Re, a Berkshire Hathaway Company, is one of the leading life/health and property/casualty reinsurers in the world. Our North American life and health reinsurance company, General Re Life Corporation, has superior financial strength ratings among life and health reinsurers. Gen Re delivers tailor-made reinsurance programs and risk management solutions for the Life, Medicare Supplement, Critical Illness and Disability markets. Through our research, we also offer valuable information and insights. For more information, visit www.genre.com.